Vaxart announced that its second-generation oral mucosal vaccine candidate, VXA-H5-02, demonstrated 100% protection against a lethal dose of H5N1 avian flu in a ferret model. The vaccine induced strong immune responses, significantly reduced viral load, and prevented death in all vaccinated ferrets, while unvaccinated ones died within six days. This oral vaccine, delivered via tablet, offers advantages like ease of administration and no cold storage, highlighting its potential for influenza prevention and pandemic preparedness. Vaxart plans further development and clinical trials to confirm these promising preclinical results in humans.
The Vaxart vaccine study is the subject, with Pluang's health sector data providing context. Of 128 health-sector US stocks priced on Pluang, 29 advanced and 91 declined today. MMED traded at USD 19.11 with a 2.70% decrease, HRTX at USD 0.38 with a 2.56% drop and a typical hold time of 35 days, and WGS at USD 67.00 down 2.23%, as of Oct 08, 2026 18:43 WIB.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
